23-seleno-25-homotaurocholic acid has been researched along with olsalazine in 1 studies
| Studies (23-seleno-25-homotaurocholic acid) | Trials (23-seleno-25-homotaurocholic acid) | Recent Studies (post-2010) (23-seleno-25-homotaurocholic acid) | Studies (olsalazine) | Trials (olsalazine) | Recent Studies (post-2010) (olsalazine) |
|---|---|---|---|---|---|
| 147 | 8 | 42 | 225 | 52 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Järnerot, G; Sandberg-Gertzén, H; Tobiasson, P; Vikterlöf, KJ | 1 |
1 trial(s) available for 23-seleno-25-homotaurocholic acid and olsalazine
| Article | Year |
|---|---|
Olsalazine does not increase the bile acid losses in subjects with a permanent ileostomy.
Topics: Adult; Aged; Aminosalicylic Acids; Bile Acids and Salts; Clinical Trials as Topic; Female; Humans; Ileostomy; Ileum; Male; Middle Aged; Taurocholic Acid | 1988 |